Hikma Pharmaceuticals, a leading medical group in the region, has signed an agreement with Boehringer Ingelheim Group of Companies to acquire the assets of Bedford Laboratories for $300 million.
Hikma is a fast growing multination
Jordan's Hikma Pharmaceuticals has formed a joint venture with Sheikh Mohammed Hussein Al Amoudi's Midroc Group to enter the Ethiopian healthcare market, where health spending is likely to more than doubl
Jordan-based Hikma Pharmaceuticals said it is reviewing options for its lucrative injectables business after receiving several unsolicited expressions of interest, driving up its shares nearly 8 per cent to a life-high.
UK-based Hikma Pharmaceuticals, a fast growing global pharmaceutical group, has posted revenue of $532.3 million for the first half of the year, marking a 34.8 per cent increase over the same period last year.
The group, with sales in m
Hikma Pharmaceuticals has partnered with Germany-based drug development firm Ergomed in an agreement that see Ergomed manage clinical trials for one of Hikma’s key anti-cancer products in Jordanian hospitals.
In turn, Hikma will provide Er